Brief: Redwood Pharma signs agreement regarding GMP production
June 29 (Reuters) - REDWOOD PHARMA AB REDWPH.ST :
* REDWOOD PHARMA SIGNS AGREEMENT REGARDING GMP PRODUCTION
* SIGNED AN AGREEMENT WITH CARBOGEN AMCIS
* CARBOGEN AMCIS WILL AVAIL REDWOOD PHARMA PRODUCTION OF NEW DRUG CANDIDATE RP101 FOR
SUBSEQUENT CLINICAL TRIAL.
Source text for Eikon: ID:nWkr1QTfzx
Further company coverage: REDWPH.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached